COMMUNIQUÉS West-GlobeNewswire

Medibio Appoints Global Healthcare & Medical Device Leader as CEO and Managing Director
02/11/2018
SYDNEY, Australia and MINNEAPOLIS, Nov. 02, 2018 (GLOBE NEWSWIRE) -- Medibio Limited ( MEB or the Company )(ASX: MEB)(OTCQB: MDBIF), a mental health technology company, announces the appointment of David B. Kaysen as [...]
United Health Products Retains Legal Counsel Ruskin Moscou Faltischek P.C to Assist in Strategic Review
02/11/2018
HENDERSON, Nev., Nov. 02, 2018 (GLOBE NEWSWIRE) -- United Health Products, Inc. (OTC: UEEC), (“UHP” or the “Company”), manufacturer and marketer of HemoStyp ® , a patented hemostatic gauze for the healthcare and wound [...]
Long-Awaited Planet 13 Vegas Superstore Opens November 1, 2018 -- CFN Media
02/11/2018
SEATTLE, Nov. 02, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Global Kinetics Corporation’s PKG® Smartwatch Provides Clinically Meaningful Improvement in Parkinson’s Disease Symptom Assessment, Management and Medication Optimization, As Well As Per Projected Patient Cost Savings
02/11/2018
Data Recently Presented at the 2018 International Congress of Parkinson’s Disease and Movement Disorders PORTSMOUTH, N.H., LONDON and MELBOURNE, Australia, Nov. 02, 2018 (GLOBE NEWSWIRE) -- Global Kinetics Pty Ltd. (GKC [...]
Phoenix Life Sciences International Receives Approval for Name Change, Symbol Change, and Completion of Consolidation of Businesses
02/11/2018
DENVER, Nov. 02, 2018 (GLOBE NEWSWIRE) -- Phoenix Life Sciences International Limited (OTC: PLSI) (“Phoenix Life”), an international adaptive healthcare solutions company, today announced it has completed the last [...]
Ascendis Pharma A/S Announces Upcoming Investor Presentations
02/11/2018
COPENHAGEN, Denmark, Nov. 02, 2018 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon ™ technology to address significant unmet medical needs, today [...]
Latin America: The Next Cannabis Frontier -- CFN Media
02/11/2018
SEATTLE, Nov. 02, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing [...]
Medibio Market Update
02/11/2018
SYDNEY, Australia and MINNEAPOLIS, Minn., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Medibio Limited ( MEB or the Company ) (ASX: MEB)(OTCQB: MDBIF), a mental health technology company, today shares a market update to the recent [...]
Teligent, Inc. to Present at Jefferies London Healthcare Conference on Wednesday November 14, 2018
02/11/2018
BUENA, N.J., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at Jefferies London Healthcare Conference. The Conference is [...]
Results of Cynata’s World-First GvHD Clinical Trial Accepted for Presentation at American Society of Hematology Annual Meeting
02/11/2018
MELBOURNE, Australia, Nov. 02, 2018 (GLOBE NEWSWIRE) -- Cynata Therapeutics Limited (ASX: CYP), a clinical-stage biotechnology company specializing in cell therapeutics, is pleased to announce that results from Cohort A [...]
Terra Tech Corp. to Report Third Quarter 2018 Earnings on Thursday, November 8, 2018
02/11/2018
IRVINE, Calif., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Terra Tech Corp. (OTCQX: TRTC) (“Terra Tech” or the “Company”), a vertically integrated, cannabis-focused agriculture company, today announced that it will release its [...]
Sarepta Therapeutics to Present at Credit Suisse 27th Annual Healthcare Conference
02/11/2018
CAMBRIDGE, Mass., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a leader in precision genetic medicine for rare diseases, today announced that management will present at the Credit Suisse [...]
Obalon Announces Third Quarter 2018 Financial Results
02/11/2018
SAN DIEGO, Nov. 02, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon [...]
Achaogen to Host Conference Call and Webcast of Third Quarter 2018 Financial Results on November 8, 2018
02/11/2018
SOUTH SAN FRANCISCO, Calif., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ: AKAO), a biopharmaceutical company discovering, developing and commercializing innovative antibacterial agents to address multi-drug [...]
Humanigen Announces Lenzilumab Study Results Accepted as Oral Presentation at the 2018 Annual Meeting of the American Society of Hematology (ASH)
02/11/2018
Study Demonstrates that GM-CSF Neutralization with Lenzilumab in Combination with Chimeric Antigen Receptor T (CAR-T) Cell Therapy Prevents the Onset of Cytokine Release Syndrome, Significantly Reduces the Severity of [...]
ORYZON Reports Financial Results and Corporate Update for the 3rd Quarter Ended September 30, 2018
02/11/2018
-$0.01/share for the 9 months ended September 30th MADRID, Spain and CAMBRIDGE, Mass., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Oryzon Genomics (ISIN Code: ES0167733015, ORY), a public clinical-stage biopharmaceutical company [...]
Checkpoint Therapeutics Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights
02/11/2018
NEW YORK, Nov. 02, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immuno-oncology biopharmaceutical company focused on the acquisition, development and [...]
Abiomed to Present at the Stephens 2018 Investment Conference in New York, NY
02/11/2018
DANVERS, Mass., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman, President and Chief [...]
Caelum Biosciences Announces Data on CAEL-101 in AL Amyloidosis Selected for Oral Presentations at 60th American Society of Hematology Annual Meeting
02/11/2018
NEW YORK, Nov. 02, 2018 (GLOBE NEWSWIRE) -- Caelum Biosciences, Inc. (“Caelum”), a company focused on developing treatments for rare and life-threatening diseases, today announced that additional global longitudinal [...]

Pages